U-2OS cells unable to respond sufficiently to cisplatin treatment undergo caspase-mediated apoptotic and caspase-independent necroptotic death, suggesting that NMNAT1 may be worth investigating further as a potential target in cancer therapy with special regard to osteosarcoma treatment. This evidence concerns the gene NMNAT1 and osteosarcoma.